Genmab A/S

GMAB

9 Followers

$19.36

-0.31%

-$0.06

7 August

Upcoming Earnings

Market Cap.

P/E

Overview Metrics Financials

GMAB Fair Price

$64.55

Undervalued by 81.4%

To display the fair price of a share, you need to be a member of Bulios Black.

My Notes

Začít psát

Profile

Genmab A/S (GMAB) is a Danish biotechnology company specializing in the research, development, and manufacturing of monoclonal antibodies for the treatment of various types of cancer and immune-related diseases. The company is known for its innovative approaches to therapies and a robust portfolio of therapeutic antibodies undergoing clinical trials. Genmab focuses on collaborations with pharmaceutical partners and leverages its advanced technology to create medicines with the potential to revolutionize the way diseases are treated. Genmab A/S (GMAB) shares might appeal to investors seeking exponential growth in the biotechnology sector.

Feed

There are no posts to show right now.